CLINICAL EXPERIENCE WITH FIRST-LINE VRD IN PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA

被引：0
|
作者：
De Miguel, Llorente Dunia [1 ]
Gil, Perez Angela [1 ]
Merchan, Munoz Beatriz [1 ]
Nuevo, Lopez Irene [1 ]
Perez, Ortega Alba [1 ]
Guillen, Garcia Helga [1 ]
Vazquez, Ramo Alejandro [1 ]
Subira, Perez Dolores [1 ]
Golbano, Lopez Nuria [1 ]
Santos, Montero Ana Belen [1 ]
Morales, Sanz Dolores [1 ]
Arbeteta, Juanis Jaime [1 ]
机构：
[1] Hosp Univ Guadalajara, Guadalajara, Spain
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-026
引用
收藏
页码：150 / 151
页数：2
相关论文
共 50 条
  • [21] The first-line effect of bortezomib-based therapy on clinical outcomes for Taiwanese patients with multiple myeloma
    Ho, C-L.
    Chen, J-H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] First line daratumumab-VTd versus VRd for transplant eligible multiple myeloma
    Byun, Ja Min
    Park, Sung-Soo
    Koh, Youngil
    Min, Chang-Ki
    Yoon, Sung-Soo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S154 - S154
  • [23] First-line Approval: Daratumumab VMP in multiple Myeloma
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (12) : 794 - 794
  • [24] Current standards for first-line therapy of multiple myeloma
    Jagannath, Sundar
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 : S207 - S214
  • [25] Trials investigate first-line thalidomide in multiple myeloma
    Owen, OG
    LANCET ONCOLOGY, 2005, 6 (01): : 6 - 6
  • [26] A phase 2 study of bortezomib as first-line therapy in patients with multiple myeloma
    Jagannath, S
    Brian, D
    Wolf, JL
    Camacho, E
    Irwin, D
    Lutzky, J
    McKinley, M
    Gabayan, E
    Mazumder, A
    Crowley, J
    Schenkein, D
    BLOOD, 2004, 104 (11) : 98A - 99A
  • [27] ASH 2021 Isatuximab supplements First-line Therapy in Patients with Multiple Myeloma
    Habel, Christoph
    ACTA HAEMATOLOGICA, 2022, 145 (02) : 232 - 232
  • [28] Risk Factors Predicting Early Relapse for Newly Diagnosed Multiple Myeloma Patients Treated with Front-Line VRD Regimen
    Cheng, Lili
    Wang, Wei
    Li, Hui
    Cai, Hao
    Zhang, Fujing
    Liu, Shuangjiao
    Zhuang, Junling
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S154 - S154
  • [29] Lymphocyte Profiling in Newly Diagnosed Multiple Myeloma: First-Line Treatment with Cyclophosphamide, Thalidomide, Dexamethasone, and Daratumumab
    Santos, Allan
    Santos, Mariane
    Leal, Joanna
    Santos, Herbert
    Santos, Juliana
    Lucas, Larissa
    Salvino, Marco Aurelio
    Bomfim, Maria da Gloria
    Hungria, Vania
    Torres, Alex
    Crusoe, Edvan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S580 - S580
  • [30] Patient characteristics associated with dose modifications for VRd among newly diagnosed multiple myeloma patients
    Ran, Tao
    Medhekar, Rohan
    Fu, Alex Z.
    Patel, Sharmila
    Kaila, Shuchita
    FUTURE ONCOLOGY, 2022, 18 (36) : 3983 - 3991
12345